Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000938206-25-000024
Filing Date
2025-05-15
Accepted
2025-05-15 07:36:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4740
  Complete submission text file 0000938206-25-000024.txt   6652
Mailing Address 25 EAST ERIE ST CHICAGO IL 60611
Business Address 25 EAST ERIE ST CHICAGO IL 60611 3125873800
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000938206 (see all company filings)

EIN.: 203634295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Subject) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91867 | Film No.: 25948738
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)